PMID- 35187144 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220223 IS - 2297-1769 (Print) IS - 2297-1769 (Electronic) IS - 2297-1769 (Linking) VI - 9 DP - 2022 TI - Efficacy of the Synergy Between Live-Attenuated and Inactivated PRRSV Vaccines Against a NADC30-Like Strain of Porcine Reproductive and Respiratory Syndrome Virus in 4-Week Piglets. PG - 812040 LID - 10.3389/fvets.2022.812040 [doi] LID - 812040 AB - The NADC30-like strain of porcine reproductive and respiratory syndrome virus (PRRSV) is a novel strain responsible for substantial economic losses to swine production in China. This study evaluated the cross-protective efficacy of the synergy between live-attenuated and inactivated PRRSV vaccines compared with a single vaccination with PRRS modified-live virus (MLV) vaccine against challenge with NADC30-like strain, v2016/ZJ/09-03. A total of 45 PRRSV free pigs were randomly divided into five groups: (1) strict control (SC); (2) positive control (PC); (3) single MLV dose (M1); (4) primed intramuscularly with MLV and boosted with killed vaccine 3 weeks later (MK1); and (5) intramuscular prime MLV boosted subcutaneously with killed vaccine B 3 weeks later (MK2). Serological tests in MK groups revealed no differences in both anti-N and anti-GP protein antibodies compared with M1 group, and failed to provide further protection against clinical signs, virus shedding, and gross lesions. However, the viremic titer, gross lung lesions, and average daily weight gain were significantly improved in the MLV vaccinated groups, suggesting that MLV provides substantial cross-protection against the NADC30-like virus. Thus, as a booster, the killed vaccine confers minimal additional protection in NADC30-like infected piglets. CI - Copyright (c) 2022 Li, Liu, Chen, Qian, Hu, Fang, Sun, Zhang, Huang, Zhang and Huang. FAU - Li, Chaosi AU - Li C AD - Boehringer Ingelheim Animal Health (Shanghai) Co. Ltd., Shanghai, China. FAU - Liu, Zhicheng AU - Liu Z AD - Maoming Branch Center of Guangdong Laboratory for LingNan Modern Agricultural Science and Technology, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China. FAU - Chen, Kai AU - Chen K AD - Boehringer Ingelheim Animal Health (Shanghai) Co. Ltd., Shanghai, China. FAU - Qian, Jie AU - Qian J AD - Boehringer Ingelheim Animal Health (Shanghai) Co. Ltd., Shanghai, China. FAU - Hu, Yulong AU - Hu Y AD - Boehringer Ingelheim Animal Health (Shanghai) Co. Ltd., Shanghai, China. FAU - Fang, Shuhe AU - Fang S AD - Boehringer Ingelheim Animal Health (Shanghai) Co. Ltd., Shanghai, China. FAU - Sun, Zhi AU - Sun Z AD - Asian Veterinary Research and Development Center, Boehringer Ingelheim (China) Investment Co., Ltd., Shanghai, China. FAU - Zhang, Chunhong AU - Zhang C AD - Maoming Branch Center of Guangdong Laboratory for LingNan Modern Agricultural Science and Technology, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China. FAU - Huang, Lv AU - Huang L AD - Boehringer Ingelheim Animal Health (Shanghai) Co. Ltd., Shanghai, China. FAU - Zhang, Jianfeng AU - Zhang J AD - Maoming Branch Center of Guangdong Laboratory for LingNan Modern Agricultural Science and Technology, Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China. FAU - Huang, Nian AU - Huang N AD - Boehringer Ingelheim Animal Health (Shanghai) Co. Ltd., Shanghai, China. LA - eng PT - Journal Article DEP - 20220202 PL - Switzerland TA - Front Vet Sci JT - Frontiers in veterinary science JID - 101666658 PMC - PMC8847452 OTO - NOTNLM OT - NADC30-like OT - heterologous-protection OT - inactivated vaccine OT - pathogenicity OT - porcine reproductive and respiratory syndrome virus OT - vaccination COIS- CL, KC, JQ, YH, SF, LH, and NH were employed by Boehringer Ingelheim Animal Health (Shanghai) Co. Ltd. ZS was employed by Boehringer Ingelheim (China) Investment Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/02/22 06:00 MHDA- 2022/02/22 06:01 PMCR- 2022/01/01 CRDT- 2022/02/21 06:05 PHST- 2021/11/11 00:00 [received] PHST- 2022/01/10 00:00 [accepted] PHST- 2022/02/21 06:05 [entrez] PHST- 2022/02/22 06:00 [pubmed] PHST- 2022/02/22 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fvets.2022.812040 [doi] PST - epublish SO - Front Vet Sci. 2022 Feb 2;9:812040. doi: 10.3389/fvets.2022.812040. eCollection 2022.